Studies in mice indicate that while a KIAA1549::BRAF fusion is sufficient to generate glioma-like lesions, this is associated with increased Iba1+ microglia infiltration and is inhibited if Ccr2-mediated microglial recruitment is blocked [12, 32]. The gene discussed is BRAF; the disease is central nervous system cancer.